Kodak Establishes Pharmaceutical Unit To Tackle Shortages

US Development Bank Signs $765m Loan For Kodak

Kodak’s new pharmaceutical unit receives a $765m loan from the US International Development Finance Corporation, through President Trump’s Defense Production Act, to produce critical pharma components that are essential but have lapsed into chronic national shortage, as defined by the FDA.

Kodak
Kodak’s new pharmaceutical wing will produce critical pharma components • Source: Shutterstock

The Eastman Kodak Company has announced successfully establishing its new business unit, Kodak Pharmaceuticals, which will produce critical pharmaceutical components that have been identified as essential but have lapsed into chronic national shortage.

The US International Development Finance Corporation agreed to grant a $765m loan to support the launch of Kodak Pharmaceuticals.

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Business

More from Generics Bulletin